Generate a tailored SOP for Dr. Mark Ormiston. Improve your application with a focused, well-structured draft.
Dr. Mark Ormiston is an Associate Professor at Queen's University in the Department of Medicine. His research primarily focuses on pulmonary arterial hypertension (PAH), a severe condition affecting blood vessels in the lungs that disproportionately impacts women between the ages of 30 and 50. His work examines the vital role of immune cells, particularly Natural Killer (NK) cells, in disease development and seeks to develop new immune-based treatments for PAH and related vascular disorders. Dr. Ormiston's research is centered on understanding how specific immune cell impairments contribute to PAH and how these cells can be genetically modified to provide targeted therapies for patients. He is investigating the broader implications of NK cell function beyond their traditional roles in cancer and viral elimination, particularly their involvement in regulating blood flow during pregnancy and how this knowledge can be used to influence lung vascular health and disease.
Department of Computing offers research-based, project-based, and course-based patterns.